Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study.
about
Epidemiology and treatment patterns of epithelial ovarian cancer.Pembrolizumab in cervical cancer: latest evidence and clinical usefulness.Survival of Node-negative Breast Cancer Patients Treated at the University Medical Centre Maribor in the Period 2000-2009.Clinical validation of chemotherapy predictors developed on global microRNA expression in the NCI60 cell line panel tested in ovarian cancer.Effect of chemotherapy on health-related quality of life among early-stage ovarian cancer survivors: a study from the population-based PROFILES registryScreening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology.Vulvar cancer in Germany: increase in incidence and change in tumour biological characteristics from 1974 to 2013.Assessing predicted age-specific breast cancer mortality rates in 27 European countries by 2020.Improving outcomes for older women with gynaecological malignancies.HE4 as a predictor of adjuvant chemotherapy resistance and survival in patients with epithelial ovarian cancer.Cancer survival in adult patients in Spain. Results from nine population-based cancer registries.Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes.International patterns and trends in ovarian cancer incidence, overall and by histologic subtype.Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma.Productivity losses and public finance burden attributable to breast cancer in Poland, 2010-2014.Survival of gynecological cancers in Turkey: where are we at?Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).Mammography Use in Portugal: National Health Survey 2014.Improvement in 5-Year Relative Survival in Cancer of the Corpus Uteri From 1993-2000 to 2001-2006 in Japan.Retrospective cohort study of breast cancer incidence, health service use and outcomes in Europe: a study of feasibility.Favorable factors for preserving bladder function after nerve-sparing radical hysterectomy: A protocol-based validation study.Loss in working years after a breast cancer diagnosis.Relationships among Type-D personality, symptoms and quality of life in patients with ovarian cancer receiving chemotherapy.Nintedanib in ovarian cancer.Trends in incidence, mortality and survival in women with breast cancer from 1985 to 2012 in Granada, Spain: a population-based studySurvival rates among women with ovarian cancers diagnosed in the area of Podkarpacie province in the years 1990-2015
P2860
Q30235358-A352AE11-1399-41D6-9BA5-49CCAF838C8FQ33757149-11A53ABF-D195-441D-9889-C7D04D18524BQ33891746-B6E869E3-7414-4475-9E87-FC2E27D9EDBCQ36320168-B148A4D3-A513-40FA-848C-89C93F0FE4DEQ37524949-16DFD474-2F39-4F8A-833E-A280824E9AC4Q37746911-879A0225-5DD9-4C0E-8B66-36905BA36BBBQ38629191-63896BC3-E535-4424-ABD1-11FB60F843C7Q38670996-0C1635B7-604D-443E-8267-185EBD027347Q38963512-7EC71E49-A662-4322-8078-29346F1A99DAQ39177243-478D3FAE-CB8D-4E05-A5FB-3CD575198FC7Q40118943-337EB937-1F7F-4993-9BC2-22C1D828BF65Q40226034-9DC14C59-DFDD-4C20-832C-6C3DA55DC6E9Q40309521-79A08558-44CE-426F-9C9F-4422E2E05D61Q40443875-B4E5C07F-251B-48E0-BE2A-E7CBDC33D2E6Q42374103-8246E4DB-0B72-43F1-AA54-9C6DDD4C4D9BQ42696735-C14E1619-5A30-4297-9C5E-80C5C3B88CA9Q46567658-7448D7DD-02AF-4E84-A113-DB9869E39276Q47143710-E2734687-48D4-48D6-B658-DDBBFE15C6D1Q47646666-041C8496-6F96-4AD9-AA5C-9F1F29F14DBCQ47659843-918361D6-F791-47BD-8252-B23720496A05Q48147101-ECD6521F-27BA-4CA8-BCC9-75224E3180DEQ50090034-0BA83027-1BA1-4B49-8C8D-9FDA7EC574E1Q50162513-BACCE886-B357-4B34-932F-2861924C9C58Q51824301-AD2153DB-1AF0-48F9-B9EA-8261686DE149Q58803134-20410DF0-9DA1-45AD-B274-D90F942EF4E2Q59136655-0AC82A14-2392-4F87-B12D-378D20C45263
P2860
Survival of women with cancers of breast and genital organs in Europe 1999-2007: Results of the EUROCARE-5 study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Survival of women with cancers ...... sults of the EUROCARE-5 study.
@en
type
label
Survival of women with cancers ...... sults of the EUROCARE-5 study.
@en
prefLabel
Survival of women with cancers ...... sults of the EUROCARE-5 study.
@en
P2093
P50
P1476
Survival of women with cancers ...... sults of the EUROCARE-5 study.
@en
P2093
EUROCARE-5 Working Group
Hilde Langseth
Maria Dolores Chirlaque Lopez
Maria José Sánchez Pérez
Pamela Minicozzi
Roberto Agresti
Sabine Siesling
Silvia Rossi
P304
P356
10.1016/J.EJCA.2015.07.022
P50
P577
2015-09-06T00:00:00Z